Association between antenatal corticosteroids and risk of serious infection in children: nationwide cohort study

AbstractObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.DesignNationwide cohort study.SettingNational Health Insurance Research Database, Birth Reporting Database, and Maternal...

Full description

Saved in:
Bibliographic Details
Published inBMJ (Online) Vol. 382; p. e075835
Main Authors Yao, Tsung-Chieh, Chang, Sheng-Mao, Wu, Chi-Shin, Tsai, Yi-Fen, Sheen, Kun-Hua, Hong, Xiumei, Chen, Hui-Yu, Wu, Ann Chen, Tsai, Hui-Ju
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 02.08.2023
BMJ Publishing Group LTD
Subjects
Online AccessGet full text
ISSN1756-1833
1756-1833
DOI10.1136/bmj-2023-075835

Cover

Abstract AbstractObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.DesignNationwide cohort study.SettingNational Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.Participants1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.Main outcome measuresIncidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.ResultsThe study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.ConclusionsThis nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period.
AbstractList To investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life. Nationwide cohort study. National Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan. 1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids. Incidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome. The study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life. This nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period.
AbstractObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.DesignNationwide cohort study.SettingNational Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.Participants1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.Main outcome measuresIncidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.ResultsThe study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.ConclusionsThis nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period.
ObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.DesignNationwide cohort study.SettingNational Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.Participants1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.Main outcome measuresIncidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.ResultsThe study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.ConclusionsThis nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period.
To investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.OBJECTIVETo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of life.Nationwide cohort study.DESIGNNationwide cohort study.National Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.SETTINGNational Health Insurance Research Database, Birth Reporting Database, and Maternal and Child Health Database, 1 January 2008 to 31 December 2019, to identify all pregnant individuals and their offspring in Taiwan.1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.PARTICIPANTS1 960 545 pairs of pregnant individuals and their singleton offspring. 45 232 children were exposed and 1 915 313 were not exposed to antenatal corticosteroids.Incidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.MAIN OUTCOME MEASURESIncidence rates were estimated for overall serious infection, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis or soft tissue infection, septic arthritis or osteomyelitis, and endocarditis during the first three, six, and 12 months of life in children exposed versus those not exposed to antenatal corticosteroids. Cox proportional hazards models were performed to quantify adjusted hazard ratios with 95% confidence intervals for each study outcome.The study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.RESULTSThe study cohort was 1 960 545 singleton children: 45 232 children were exposed to one course of antenatal corticosteroids and 1 915 313 children were not exposed to antenatal corticosteroids. The adjusted hazard ratios for overall serious infection, sepsis, pneumonia, and acute gastroenteritis among children exposed to antenatal corticosteroids were significantly higher than those not exposed to antenatal corticosteroids during the first six months of life (adjusted hazard ratio 1.32, 95% confidence interval 1.18 to 1.47, P<0.001, for overall serious infection; 1.74, 1.16 to 2.61, P=0.01, for sepsis; 1.39, 1.17 to 1.65, P<0.001, for pneumonia; and 1.35, 1.10 to 1.65, P<0.001, for acute gastroenteritis).Similarly, the adjusted hazard ratios for overall serious infection (P<0.001), sepsis (P=0.02), pneumonia (P<0.001), and acute gastroenteritis (P<0.001) were significantly higher from birth to 12 months of life. In the sibling matched cohort, the results were comparable with those observed in the whole cohort, with a significantly increased risk of sepsis in the first six (P=0.01) and 12 (P=0.04) months of life.This nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period.CONCLUSIONSThis nationwide cohort study found that children exposed to one course of antenatal corticosteroids were significantly more likely to have an increased risk of serious infection during the first 12 months of life. These findings suggest that before starting treatment, the long term risks of rare but serious infection associated with antenatal corticosteroids should be carefully weighed against the benefits in the perinatal period.
Author Wu, Chi-Shin
Tsai, Hui-Ju
Yao, Tsung-Chieh
Sheen, Kun-Hua
Hong, Xiumei
Wu, Ann Chen
Chang, Sheng-Mao
Tsai, Yi-Fen
Chen, Hui-Yu
Author_xml – sequence: 1
  givenname: Tsung-Chieh
  orcidid: 0000-0002-5457-1402
  surname: Yao
  fullname: Yao, Tsung-Chieh
  email: yao@adm.cgmh.org.tw
  organization: School of Medicine, Chang Gung University College of Medicine, Taoyuan, Taiwan
– sequence: 2
  givenname: Sheng-Mao
  surname: Chang
  fullname: Chang, Sheng-Mao
  organization: Department of Statistics, National Taipei University, Taipei, Taiwan
– sequence: 3
  givenname: Chi-Shin
  surname: Wu
  fullname: Wu, Chi-Shin
  organization: Department of Psychiatry, National Taiwan University Hospital, Yunlin Branch, Douliu, Taiwan
– sequence: 4
  givenname: Yi-Fen
  surname: Tsai
  fullname: Tsai, Yi-Fen
  organization: Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan
– sequence: 5
  givenname: Kun-Hua
  surname: Sheen
  fullname: Sheen, Kun-Hua
  organization: Department of Medical Science, National Tsing-Hua University, Hsinchu, Taiwan
– sequence: 6
  givenname: Xiumei
  surname: Hong
  fullname: Hong, Xiumei
  organization: Department of Population, Family, and Reproductive Health, Center on Early Life Origins of Disease, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
– sequence: 7
  givenname: Hui-Yu
  surname: Chen
  fullname: Chen, Hui-Yu
  organization: Department of Pharmacy, Chang Gung Memorial Hospital, Taoyuan, Taiwan
– sequence: 8
  givenname: Ann Chen
  surname: Wu
  fullname: Wu, Ann Chen
  organization: Harvard Medical School, Boston, MA, USA
– sequence: 9
  givenname: Hui-Ju
  surname: Tsai
  fullname: Tsai, Hui-Ju
  organization: Department of Medical Science, National Tsing-Hua University, Hsinchu, Taiwan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37532264$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1LXDEUxUNRqp267k4Cbgrlab7nPXci_RAEN-065CU3mOmbZEzyEP97MzNaiuAqF-7vnBzu-YQOYoqA0BdKzinl6mJcrzpGGO_IUvZcfkDHdClVR3vOD_6bj9BJKStCGrnsByU_oiO-lJwxJY7R5qqUZIOpIUU8Qn0EiNjECtFUM2Gbcg02lQo5BVfaxuEcyl-cPC6QQ5oLDtGD3elDxPY-TC5DvMRx5_kYHDSX--aDS53d02d06M1U4OTlXaA_P77_vv7V3d79vLm-uu1GofraUUsHEJ554gWRzo3OyoERQSk4GKwVivkByCjaIZR00jrO-kEYYj0bR-r4An3d-25yepihVL0OxcI0mQgttWa9kEoqJlhDz96gqzTn2NJtKdFseftmgU5fqHlcg9ObHNYmP-nXWzZA7gGbUykZvLah7o5QswmTpkRva9OtNr2tTe9ra7qLN7pX6_cV3_aK7eJf1vfoZzE-qJk
CitedBy_id crossref_primary_10_1136_bmjmed_2024_000995
crossref_primary_10_1186_s12884_024_07013_w
crossref_primary_10_3390_pathogens14010089
crossref_primary_10_7759_cureus_67977
crossref_primary_10_1038_s41372_023_01831_0
crossref_primary_10_1097_INF_0000000000004440
crossref_primary_10_1007_s40278_023_45390_5
crossref_primary_10_1111_1756_185X_15103
crossref_primary_10_1001_jamapediatrics_2024_4409
crossref_primary_10_1001_jamanetworkopen_2024_53284
crossref_primary_10_1038_s41390_024_03092_9
crossref_primary_10_1080_14656566_2025_2475190
crossref_primary_10_1159_000540078
crossref_primary_10_1038_s41390_024_03723_1
crossref_primary_10_1093_ibd_izad316
crossref_primary_10_1507_endocrj_EJ23_0725
crossref_primary_10_1002_uog_27619
crossref_primary_10_1080_14767058_2024_2434059
Cites_doi 10.1001/jamapediatrics.2022.0483
10.1136/bmj.330.7497.960
10.1016/j.placenta.2007.04.002
10.1001/jama.1995.03520290065031
10.1203/00006450-200003000-00003
10.1016/j.mehy.2007.07.049
10.1371/journal.pone.0112257
10.1002/14651858.CD004454.pub4
10.1016/S1095-6433(01)00308-7
10.1001/jamadermatol.2019.1121
10.1046/j.1365-2265.1997.1230939.x
10.1001/jama.2020.3937
10.1002/aur.2835
10.1111/j.1742-7843.2006.pto_293.x
10.7326/M20-0432
10.1080/14767058.2020.1731455
10.1111/1471-0528.16677
10.1016/j.ajog.2022.10.002
10.1164/ajrccm.165.7.2105003
10.1159/000499361
10.1159/000502650
10.1001/jamapediatrics.2021.0433
10.1016/j.jpeds.2022.09.032
10.1002/sim.1903
10.1111/1471-0528.17027
10.1136/bmj.j1415
10.1016/S0095-5108(18)30093-9
10.1097/AOG.0000000000002237
10.1001/jamanetworkopen.2022.28518
ContentType Journal Article
Copyright Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2023 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: 2023 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 9YT
ACMMV
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88I
8AF
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AN0
ASE
AZQEC
BBNVY
BENPR
BHPHI
BTHHO
CCPQU
DWQXO
FPQ
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K6X
K9.
KB0
LK8
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
Q9U
7X8
DOI 10.1136/bmj-2023-075835
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Science Database (Alumni Edition)
STEM Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
British Nursing Index
ProQuest Central Essentials Local Electronic Collection Information
Biological Science Database
ProQuest Central
Natural Science Collection
BMJ Journals
ProQuest One
ProQuest Central Korea
British Nursing Index (BNI) (1985 to Present)
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
British Nursing Index
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Research Library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
British Nursing Index
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

Research Library Prep
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: ACMMV
  name: BMJ Journals:Open Access
  url: https://journals.bmj.com/
  sourceTypes: Publisher
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-1833
ExternalDocumentID 37532264
10_1136_bmj_2023_075835
bmj
Genre Journal Article
GeographicLocations Taiwan
GeographicLocations_xml – name: Taiwan
GroupedDBID 23N
39C
4.4
40O
53G
5GY
7RV
7X7
88I
8AF
8F7
8FE
8FH
8FI
8FJ
8G5
9YT
AACGO
AANCE
AAWJN
ABIVO
ABJNI
ABPLY
ABTLG
ABUWG
ABVAJ
ACGFS
ACGOD
ACMFJ
ACMMV
ACPRK
AFKRA
AGFXO
AHMBA
AHNKE
AHQMW
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
BTHHO
C45
CCPQU
CS3
DWQXO
EBS
EJD
F5P
FYUFA
GNUQQ
GUQSH
H13
HAJ
HCIFZ
HMCUK
HZ~
JLS
JSG
L7B
LK8
M2O
M2P
M7P
NAPCQ
NXWIF
O9-
OVD
PHGZT
PQQKQ
PROAC
R53
RHI
RMJ
RV8
TEORI
UKHRP
VVN
WOQ
YFH
YQY
AAYXX
CITATION
PHGZM
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
3V.
7XB
8FK
AN0
ASE
FPQ
K6X
K9.
MBDVC
PKEHL
PQEST
PQUKI
PUEGO
Q9U
7X8
ID FETCH-LOGICAL-b468t-1c19e4f2f0f405ddbdc5920411ede9cc462f9e0b413665d5cd32894a0cf2bb1d3
IEDL.DBID 9YT
ISSN 1756-1833
IngestDate Fri Sep 05 13:20:46 EDT 2025
Mon Sep 08 14:14:51 EDT 2025
Mon Jul 21 05:57:00 EDT 2025
Tue Jul 01 02:24:28 EDT 2025
Thu Apr 24 23:10:23 EDT 2025
Thu Apr 24 22:50:41 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b468t-1c19e4f2f0f405ddbdc5920411ede9cc462f9e0b413665d5cd32894a0cf2bb1d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-5457-1402
OpenAccessLink https://bmj.com/content/382/bmj-2023-075835.full
PMID 37532264
PQID 2844894341
PQPubID 2043523
ParticipantIDs proquest_miscellaneous_2845656242
proquest_journals_2844894341
pubmed_primary_37532264
crossref_citationtrail_10_1136_bmj_2023_075835
crossref_primary_10_1136_bmj_2023_075835
bmj_journals_10_1136_bmj_2023_075835
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230802
2023-08-02
PublicationDateYYYYMMDD 2023-08-02
PublicationDate_xml – month: 8
  year: 2023
  text: 20230802
  day: 2
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMJ (Online)
PublicationTitleAbbrev BMJ
PublicationTitleAlternate BMJ
PublicationYear 2023
Publisher British Medical Journal Publishing Group
BMJ Publishing Group LTD
Publisher_xml – name: British Medical Journal Publishing Group
– name: BMJ Publishing Group LTD
References (ref2) 2017; 130
Yao, Wang, Chang (ref16) 2021; 175
Ryu, Oh, Sohn, Lee (ref12) 2019; 116
Yao, Huang, Chang, Tsai, Wu, Tsai (ref15) 2020; 173
Gilstrap, Christensen, Clewell (ref1) 1995; 273
Mamdani, Sykora, Li (ref22) 2005; 330
Ninan, Liyanage, Murphy, Asztalos, McDonald (ref25) 2022; 176
Lunceford, Davidian (ref21) 2004; 23
Chien, Wu, Chang, Cheong, Yao, Tsai (ref18) 2022; 15
Matthews (ref29) 2000; 47
Orsida, Krozowski, Walters (ref30) 2002; 165
Räikkönen, Gissler, Tapiainen, Kajantie (ref9) 2022; 5
Vidaeff, Belfort, Kemp (ref6) 2023; 228
Haagsman, Diemel (ref28) 2001; 129
Stock, Thomson, Papworth (ref4) 2022; 129
Baisden, Sonne, Joshi, Ganapathy, Shekhawat (ref8) 2007; 28
Waljee, Rogers, Lin (ref14) 2017; 357
Wu, Lai, Gau, Wang, Tsai (ref19) 2014; 9
Sweet, Carnielli, Greisen (ref5) 2019; 115
McGoldrick, Stewart, Parker, Dalziel (ref24) 2020; 12
Liang, Tsai, Kuo, Tsai (ref13) 2021; 128
Alenius, Kajantie, Sund (ref23) 2023; 253
Benediktsson, Calder, Edwards, Seckl (ref7) 1997; 46
Dommasch, Kim, Lee, Gagne (ref17) 2019; 155
Glynn, Schneeweiss, Stürmer (ref20) 2006; 98
Pole, Mustard, To, Beyene, Allen (ref26) 2008; 70
Merrill, Ballard (ref27) 1998; 25
Räikkönen, Gissler, Kajantie (ref10) 2020; 323
Beksac, Korkmaz, Kasapoglu, Ozdemir, Cosgun, Tanacan (ref11) 2022; 35
2023080221000915000_382.aug02_8.e075835.26
2023080221000915000_382.aug02_8.e075835.27
2023080221000915000_382.aug02_8.e075835.24
2023080221000915000_382.aug02_8.e075835.25
2023080221000915000_382.aug02_8.e075835.22
2023080221000915000_382.aug02_8.e075835.23
2023080221000915000_382.aug02_8.e075835.20
2023080221000915000_382.aug02_8.e075835.21
2023080221000915000_382.aug02_8.e075835.28
2023080221000915000_382.aug02_8.e075835.29
2023080221000915000_382.aug02_8.e075835.30
2023080221000915000_382.aug02_8.e075835.15
2023080221000915000_382.aug02_8.e075835.1
2023080221000915000_382.aug02_8.e075835.16
2023080221000915000_382.aug02_8.e075835.13
2023080221000915000_382.aug02_8.e075835.14
2023080221000915000_382.aug02_8.e075835.11
2023080221000915000_382.aug02_8.e075835.12
2023080221000915000_382.aug02_8.e075835.10
2023080221000915000_382.aug02_8.e075835.19
2023080221000915000_382.aug02_8.e075835.17
2023080221000915000_382.aug02_8.e075835.18
2023080221000915000_382.aug02_8.e075835.8
2023080221000915000_382.aug02_8.e075835.9
2023080221000915000_382.aug02_8.e075835.6
2023080221000915000_382.aug02_8.e075835.7
2023080221000915000_382.aug02_8.e075835.4
2023080221000915000_382.aug02_8.e075835.5
2023080221000915000_382.aug02_8.e075835.2
2023080221000915000_382.aug02_8.e075835.3
37532272 - BMJ. 2023 Aug 2;382:1722
References_xml – volume: 130
  start-page: e102
  year: 2017
  ident: ref2
  article-title: Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation
  publication-title: Obstet Gynecol
– volume: 116
  start-page: 369
  year: 2019
  ident: ref12
  article-title: The Associations between Antenatal Corticosteroids and In-Hospital Outcomes of Preterm Singleton Appropriate for Gestational Age Neonates according to the Presence of Maternal Histologic Chorioamnionitis
  publication-title: Neonatology
– volume: 70
  start-page: 981
  year: 2008
  ident: ref26
  article-title: Antenatal steroid therapy and childhood asthma: Is there a possible link?
  publication-title: Med Hypotheses
– volume: 175
  start-page: 723
  year: 2021
  ident: ref16
  article-title: Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children
  publication-title: JAMA Pediatr
– volume: 15
  start-page: 2409
  year: 2022
  ident: ref18
  article-title: Associations between parental psychiatric disorders and autism spectrum disorder in the offspring
  publication-title: Autism Res
– volume: 176
  year: 2022
  ident: ref25
  article-title: Evaluation of Long-term Outcomes Associated With Preterm Exposure to Antenatal Corticosteroids: A Systematic Review and Meta-analysis
  publication-title: JAMA Pediatr
– volume: 47
  start-page: 291
  year: 2000
  ident: ref29
  article-title: Antenatal glucocorticoids and programming of the developing CNS
  publication-title: Pediatr Res
– volume: 323
  start-page: 1924
  year: 2020
  ident: ref10
  article-title: Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children
  publication-title: JAMA
– volume: 115
  start-page: 432
  year: 2019
  ident: ref5
  article-title: European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update
  publication-title: Neonatology
– volume: 253
  start-page: 135
  year: 2023
  ident: ref23
  article-title: Risk-Taking Behavior of Adolescents and Young Adults Born Preterm
  publication-title: J Pediatr
– volume: 129
  start-page: e35
  year: 2022
  ident: ref4
  article-title: Antenatal corticosteroids to reduce neonatal morbidity and mortality: Green-top Guideline No. 74
  publication-title: BJOG
– volume: 273
  start-page: 413
  year: 1995
  ident: ref1
  article-title: Effect of corticosteroids for fetal maturation on perinatal outcomes
  publication-title: JAMA
– volume: 12
  year: 2020
  ident: ref24
  article-title: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
  publication-title: Cochrane Database Syst Rev
– volume: 330
  start-page: 960
  year: 2005
  ident: ref22
  article-title: Reader’s guide to critical appraisal of cohort studies: 2. Assessing potential for confounding
  publication-title: BMJ
– volume: 25
  start-page: 983
  year: 1998
  ident: ref27
  article-title: Antenatal hormone therapy for fetal lung maturation
  publication-title: Clin Perinatol
– volume: 228
  start-page: 129
  year: 2023
  ident: ref6
  article-title: Updating the balance between benefits and harms of antenatal corticosteroids
  publication-title: Am J Obstet Gynecol
– volume: 128
  start-page: 1497
  year: 2021
  ident: ref13
  article-title: Antenatal corticosteroid therapy in late preterm delivery: a nationwide population-based retrospective study in Taiwan
  publication-title: BJOG
– volume: 9
  year: 2014
  ident: ref19
  article-title: Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan
  publication-title: PLoS One
– volume: 46
  start-page: 161
  year: 1997
  ident: ref7
  article-title: Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure
  publication-title: Clin Endocrinol (Oxf)
– volume: 28
  start-page: 1082
  year: 2007
  ident: ref8
  article-title: Antenatal dexamethasone treatment leads to changes in gene expression in a murine late placenta
  publication-title: Placenta
– volume: 173
  start-page: 325
  year: 2020
  ident: ref15
  article-title: Association Between Oral Corticosteroid Bursts and Severe Adverse Events: A Nationwide Population-Based Cohort Study
  publication-title: Ann Intern Med
– volume: 165
  start-page: 1010
  year: 2002
  ident: ref30
  article-title: Clinical relevance of airway 11beta-hydroxysteroid dehydrogenase type II enzyme in asthma
  publication-title: Am J Respir Crit Care Med
– volume: 98
  start-page: 253
  year: 2006
  ident: ref20
  article-title: Indications for propensity scores and review of their use in pharmacoepidemiology
  publication-title: Basic Clin Pharmacol Toxicol
– volume: 5
  year: 2022
  ident: ref9
  article-title: Associations Between Maternal Antenatal Corticosteroid Treatment and Psychological Developmental and Neurosensory Disorders in Children
  publication-title: JAMA Netw Open
– volume: 35
  start-page: 705
  year: 2022
  ident: ref11
  article-title: Antenatal corticosteroids for women at risk of preterm delivery: the “Emperor’s New Clothes” tale in medical practice
  publication-title: J Matern Fetal Neonatal Med
– volume: 23
  start-page: 2937
  year: 2004
  ident: ref21
  article-title: Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study
  publication-title: Stat Med
– volume: 357
  start-page: j1415
  year: 2017
  ident: ref14
  article-title: Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
  publication-title: BMJ
– volume: 155
  start-page: 1142
  year: 2019
  ident: ref17
  article-title: Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis
  publication-title: JAMA Dermatol
– volume: 129
  start-page: 91
  year: 2001
  ident: ref28
  article-title: Surfactant-associated proteins: functions and structural variation
  publication-title: Comp Biochem Physiol A Mol Integr Physiol
– ident: 2023080221000915000_382.aug02_8.e075835.25
  doi: 10.1001/jamapediatrics.2022.0483
– ident: 2023080221000915000_382.aug02_8.e075835.22
  doi: 10.1136/bmj.330.7497.960
– ident: 2023080221000915000_382.aug02_8.e075835.8
  doi: 10.1016/j.placenta.2007.04.002
– ident: 2023080221000915000_382.aug02_8.e075835.1
  doi: 10.1001/jama.1995.03520290065031
– ident: 2023080221000915000_382.aug02_8.e075835.29
  doi: 10.1203/00006450-200003000-00003
– ident: 2023080221000915000_382.aug02_8.e075835.26
  doi: 10.1016/j.mehy.2007.07.049
– ident: 2023080221000915000_382.aug02_8.e075835.19
  doi: 10.1371/journal.pone.0112257
– ident: 2023080221000915000_382.aug02_8.e075835.24
  doi: 10.1002/14651858.CD004454.pub4
– ident: 2023080221000915000_382.aug02_8.e075835.28
  doi: 10.1016/S1095-6433(01)00308-7
– ident: 2023080221000915000_382.aug02_8.e075835.17
  doi: 10.1001/jamadermatol.2019.1121
– ident: 2023080221000915000_382.aug02_8.e075835.7
  doi: 10.1046/j.1365-2265.1997.1230939.x
– ident: 2023080221000915000_382.aug02_8.e075835.10
  doi: 10.1001/jama.2020.3937
– ident: 2023080221000915000_382.aug02_8.e075835.18
  doi: 10.1002/aur.2835
– ident: 2023080221000915000_382.aug02_8.e075835.20
  doi: 10.1111/j.1742-7843.2006.pto_293.x
– ident: 2023080221000915000_382.aug02_8.e075835.15
  doi: 10.7326/M20-0432
– ident: 2023080221000915000_382.aug02_8.e075835.11
  doi: 10.1080/14767058.2020.1731455
– ident: 2023080221000915000_382.aug02_8.e075835.3
– ident: 2023080221000915000_382.aug02_8.e075835.13
  doi: 10.1111/1471-0528.16677
– ident: 2023080221000915000_382.aug02_8.e075835.6
  doi: 10.1016/j.ajog.2022.10.002
– ident: 2023080221000915000_382.aug02_8.e075835.30
  doi: 10.1164/ajrccm.165.7.2105003
– ident: 2023080221000915000_382.aug02_8.e075835.5
  doi: 10.1159/000499361
– ident: 2023080221000915000_382.aug02_8.e075835.12
  doi: 10.1159/000502650
– ident: 2023080221000915000_382.aug02_8.e075835.16
  doi: 10.1001/jamapediatrics.2021.0433
– ident: 2023080221000915000_382.aug02_8.e075835.23
  doi: 10.1016/j.jpeds.2022.09.032
– ident: 2023080221000915000_382.aug02_8.e075835.21
  doi: 10.1002/sim.1903
– ident: 2023080221000915000_382.aug02_8.e075835.4
  doi: 10.1111/1471-0528.17027
– ident: 2023080221000915000_382.aug02_8.e075835.14
  doi: 10.1136/bmj.j1415
– ident: 2023080221000915000_382.aug02_8.e075835.27
  doi: 10.1016/S0095-5108(18)30093-9
– ident: 2023080221000915000_382.aug02_8.e075835.2
  doi: 10.1097/AOG.0000000000002237
– ident: 2023080221000915000_382.aug02_8.e075835.9
  doi: 10.1001/jamanetworkopen.2022.28518
– reference: 37532272 - BMJ. 2023 Aug 2;382:1722
SSID ssj0002378965
Score 2.5462604
Snippet AbstractObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six,...
To investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12 months of...
ObjectiveTo investigate the associations between exposure to antenatal corticosteroids and serious infection in children during the first three, six, and 12...
SourceID proquest
pubmed
crossref
bmj
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e075835
SubjectTerms Adrenal Cortex Hormones - adverse effects
Asthma
Birth weight
Cellulitis
Child
Child & adolescent mental health
Children
Children & youth
Childrens health
Chronic obstructive pulmonary disease
Cohort analysis
Cohort Studies
Congenital diseases
Corticosteroids
Drug abuse
Drug dosages
Encephalitis
Endocarditis
Female
Gastroenteritis
Hospitals
Humans
Hypertension
Immunology
Immunomodulators
Infections
Maternal & child health
Meningitis
Mental disorders
Multiple births
Newborn babies
Offspring
Osteomyelitis
Pneumonia
Pregnancy
Premature Birth
Pyelonephritis
Rheumatoid arthritis
Sepsis
Siblings
Socioeconomic factors
Steroids
Taiwan - epidemiology
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3LS8MwGA86QbyIb6dTInjwEtemaZp6ERFFBD052K00L1C0m9vEf9_va9NND_NW8mjLL1_yPfI9CDl3iTLG25LxTKVMWOdYqXLOyizNSp3HykYYjfz0LB8G4nGYDoPBbRrcKtszsT6o7cigjbwPx6jAXOEivh5_MqwahberoYTGKlmrU5cBPWfDbG5j4UmmcpmGjD5xIvv6441hwXAGnFJhibdVaPnLkpbImTW_ud8im0FQpDfNym6TFVftkPWncBW-S8a_gKXB24oiTBUaZCgolTARIzgmo1c7hR5L0Y2cjjxFqgOFn7aOWBU80Taq-4o29sHvV-sols-dzGidg3aPDO7vXm4fWCifwLSQasZiE-dOeO4jD1KZtdqaNOeRiGNnXW6MkNznLtLAxqRMbWpsAtqXKCPjudaxTfZJpxpV7pBQJ3WUArdPPMhPwOuU9xw2svNSmDxSrkvOAccikP-0qDWLRBbYiHAXDdxdctkCXZiQghwrYbwvn3AxnzBusm8sH9prV27xHwui6ZKzeTdsILwVKSsHWOMYFGpBVOmSg2bF599KQJnDSOOj_19-TDYaolIs4j3SmU2-3AnIKjN9WhPkDxQ26FE
  priority: 102
  providerName: ProQuest
Title Association between antenatal corticosteroids and risk of serious infection in children: nationwide cohort study
URI https://bmj.com/content/382/bmj-2023-075835.full
https://www.ncbi.nlm.nih.gov/pubmed/37532264
https://www.proquest.com/docview/2844894341
https://www.proquest.com/docview/2845656242
Volume 382
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEB7ygJBLadLXtumiQg69KJUlWZZ7S0NCCGwoJSnbk7FekNB6w8Yhf78zfmwfsJCTjSVh-9OI-WakmQE4jMp6n0LNZWFzrkOMvLal5HWRF7UrMxsERSPPLs35tb6Y5_MNEGMsjPt120cyUG6mpv2krKRnnKp8c1RvSBiOyDG9CdtUmqSrWfDjauVVkaqwpcmHHD6ZMv8P3oUdhQydwkdRm2Djv_poDcnslM3Zc3g2sER23E_rHmzEZh92ZsM--Au4-wtVNhy1YoRRQ94YhhYlDqTwjeXiJtxjS2B0hpwtEiORQ2ufjaewGrxjY0j3Z9Y7Bx9vQmRUO3fZsi4B7Uu4Pju9OjnnQ-0E7rSxLc98VkadZBIJKVkILvi8lEJnWQyx9F4bmcooHOowY_KQ-6DQ9NK18Ek6lwX1CraaRRPfAIvGiRxVvUoIGio6m5LEVRyT0b4UNk7gEHGsBtm_rzqzQpmKHhLyVY_8BI5GoCs_5B-nMhg_1w_4uBpw16feWN_1YJy5P9-BildTdnmdTeDDqhlXD22J1E1ErKkPMVrkKRN43c_46l2jnLx92v-9g91eziwX8gC22uVDfI-EpXVT2CzmxbST1ClsH5_MZt_x-uX08uu33xi76K4
linkProvider BMJ Publishing Group Ltd
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1dT9RAcAJHorwYEJVTxDXBxJeVdrvd25IYIwg5Pu5iDCS81e5XgtH2vDtC_FP8Rmau7aEP5xtvzXZ328zMztfOB8COT7S1wRVc9HTKpfOeFzoTvOilvcJksXYRZSMPhqp_IU8u08sluG1zYSissuWJM0btKks-8l1ko5Jqhcv40-g3p65RdLvattCoyeLU_7lBk23y8fgL4vedEEeH5wd93nQV4EYqPeWxjTMvgwhRQGXFOeNsmolIxrF3PrNWKhEyHxnk7kqlLrUuQaNEFpENwpjYJbjvMqxIymjtwMr-4fDrt7lXRyQ9nam0qSGEO-yaXz84tSjnKJs1NZVbxpF_heACzXYm4Y7W4EmjmrLPNS2tw5Ivn8KjQXP5vgGjv1DJmvguRogpyQXE0IzFhZQzMq6u3ATfOEaB66wKjOi8up6wNvSrxCfW5pHvsdojeXPlPKOGveMpm1W9fQYXDwLa59Apq9JvAvPKRCnqF0lAjQ2lqw5BIOvwQUmbRdp3YQfhmDcHbpLPbJlE5TRI4M5rcHfhQwvo3DZFz6n3xs_FC97PF4zqeh-Lp261mLv_j3sy7cLb-Ws8snQPU5QeYU1zSI1G5agLL2qMz7-VoPlIuc0v_7_5G3jcPx-c5WfHw9NXsFoTmOaR2ILOdHztX6OmNDXbDXky-P7QJ-IOjsMneQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bT9RAFD7hkhBfjOCFRZQxwcSXcdvpdDo1McSAGxAhPkiyb7VzSzDaLrtLiH_NX-c5vSzysLzx1rQzbXNu852ZcwHY94m2NriSi0ynXDrvealzwcsszUqTx9pFlI18dq6OL-SXcTpegb99LgyFVfY2sTHUrra0Rz5EMyqpVriMh6ELi_h2NDqYXHHqIEUnrX07jVZETv2fG3TfZh9PjpDXb4UYff5-eMy7DgPcSKXnPLZx7mUQIQoIXJwzzqa5iGQce-dza6USIfeRQUuvVOpS6xJ0UGQZ2SCMiV2C712F9SxBVIW6lI2zxf6OSDKdq7SrJoTzh-b3T07Nyjmu0pray63inbvL4RKM26x1oyfwuAOp7FMrVZuw4qst2DjrjuGfwuQ_prIu0osRiyraDGLo0OJEyh6Z1pduhk8coxB2VgdGEl9fz1gfBFbhFeszyj-wdm_y5tJ5Rq17p3PW1L99BhcPQtjnsFbVld8G5pWJUkQaSUDshuusDkGgEfFBSZtH2g9gH-lYdKo3KxqvJlEF3SRyFy25B_C-J3Rhu_Ln1IXj1_IJ7xYTJm3lj-VDd3vO3f7HrcAO4M3iMSovnciUlUda0xgC1AiTBvCi5fjiWwk6kpTlvHP_y_dgA_Wg-HpyfvoSHrXypXkkdmFtPr32rxAyzc3rRjYZ_HhoZfgH9TEqQA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+antenatal+corticosteroids+and+risk+of+serious+infection+in+children%3A+nationwide+cohort+study&rft.jtitle=BMJ.+British+medical+journal+%28Clinical+research+ed.%29&rft.au=Yao%2C+Tsung-Chieh&rft.au=Chang%2C+Sheng-Mao&rft.au=Wu%2C+Chi-Shin&rft.au=Tsai%2C+Yi-Fen&rft.date=2023-08-02&rft.eissn=1756-1833&rft.volume=382&rft.spage=e075835&rft_id=info:doi/10.1136%2Fbmj-2023-075835&rft_id=info%3Apmid%2F37532264&rft.externalDocID=37532264
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-1833&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-1833&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-1833&client=summon